A FAIR-Decide framework for pharmaceutical R&D: FAIR data cost-benefit assessment

Ebtisam Alharbi,Rigina Skeva,Nick Juty,Caroline Jay,Carole Goble
DOI: https://doi.org/10.1016/j.drudis.2023.103510
Abstract:The FAIR (findable, accessible, interoperable and reusable) principles are data management and stewardship guidelines aimed at increasing the effective use of scientific research data. Adherence to these principles in managing data assets in pharmaceutical research and development (R&D) offers pharmaceutical companies the potential to maximise the value of such assets, but the endeavour is costly and challenging. We describe the 'FAIR-Decide' framework, which aims to guide decision-making on the retrospective FAIRification of existing datasets by using business analysis techniques to estimate costs and expected benefits. This framework supports decision-making on FAIRification in the pharmaceutical R&D industry and can be integrated into a company's data management strategy.
What problem does this paper attempt to address?